Newsletter | December 2022.
.
myBrain Tech team wishes you a happy new year 2023 ⭐️
During this year of 2022, we have dedicated ourselves to make our solution more complete and ergonomic through many updates designed to optimize the way you realize your experiments.
The end of the year is for us the opportunity to come back on the major improvements of our solution, always respectful of the regulations, which allow us today to reinforce our presence on the pharma-medtech market.
We are very proud to have accompanied our customers in the launch of a large number of studies during the year and we look forward to seeing you at the beginning of the year.
Happy New Year to all! 😊
Summary |
Product Updates 🔍 |
Pharma-Medtech Market 🩺 |
Retrospective 2022
#ProductUpdates 🔍
Our comprehensive platform explores the brain to decipher human cognition, behavior and emotions, using multiple artificial intelligences and neuroscience. Thanks to our customers’ feedback, we have kept improving our solution to best meet their specific needs.
Global Brain Assessment 🧠
The Global Brain Assessment is a configurable program that will adapt to your protocol needs. It allows more flexibility to customize protocols during a product test and clearly visualize neuromarkers to better understand your users.
Analytics 📊
In order to optimize your decision making, the analytics have been redesigned to facilitate navigation, to see the results more clearly and to quickly determine the effects of your products on your subjects.
We have also developed a new feature to go deeper into your subjects’ mental states understanding by visualizing the evolution of each neuromarker level against time for all sessions: the temporal visualization.
New hybrid headset VRxEEG 🎧
This new two-in-one helmet integrating electrodes to measure brain activity which, coupled with a virtual reality simulator, provides an immersive experience to analyze the mental states of subjects while a task.
Medical Device Regulation
#Pharma-Medtech 🩺
myBrain Technologies takes great care to make sure that every improvement we provide to our solution is in line with the regulations in force in the pharma-medtech market, in order to ensure our involvement in this sector.
Indeed, we aim to deliver an AI-powered brain data platform providing digital neuromarkers to improve personalized, predictive and integrated patient care.
✓ Accelerate clinical trials and enable new treatments.
✓ Optimize the care pathway with efficient and rapid EEG monitoring by adapting to each individual.
Therefore, we strive to ensure that our quality management system guarantees customer satisfaction through consistent and standardised processes together with centralised and organised quality control policies.
We’re preparing some nice surprises for 2023 with articles on the future of digital health or even the hybrid clinical trials. In the meantime, we’ll leave you with some holiday reading related to Health and Ethics 🤓👇
Computational Psychiatry.
Neurosicence and AI are about to revolutionize medicine, especially psychiatry. Neurotechnologies offer a range of new tools based on objective and empirical data which will revolutionize the diagnosis and prevention of psychiatric pathologies.
A milestone for NeuroEthics.
The capacity of neurotechnologies to probe and interfere with brain activity challenges notions of identity, integrity and autonomy of human being. Recent initiatives aim to help actors anticipate and address ethical, legal and social challenges, while promoting innovation in this area.
What future for IA in Europe.
On April 21, 2021, the European Commission published a proposed regulation on Artificial Intelligence, the Artificial Intelligence Act, which aims to establish safe and harmonized rules for this innovative field. We decrypt!
© 2022 myBrain Technologies, All rights reserved.
50 Avenue Claude Vellefaux
75010 Paris
Vivian Panah-Izadi
Chargée de communication
Related Articles
A milestone for NeuroEthics
Neurotechnologies are no longer confined to research laboratories. They are fully integrated in our societies, whether in the medical field or beyond.
The benefits of collecting EEG neuroimaging insights in clinical trials.
In clinical trials, brain monitoring EEG is facilitating the measurement of complex clinical endpoints. EEG as a biomarker provides safe, objective an
Newsletter | December 2022.
During this year of 2022, we have dedicated ourselves to make our solution more complete and ergonomic through many updates designed to optimize th
Newsletter | November 2022.
The end of 2022 marks a major step forward in the neurotechnology sector in France: the presentation of a Charter for a responsible development of ne
A milestone for NeuroEthics.
The capacity of neurotechnologies to probe and interfere with brain activity challenges notions of identity, integrity and autonomy of human being. Re
Newsletter | October 2022.
To travel miles in full peace of mind, in a car that understands and anticipates every need of the driver on the road, is becoming a reality! With it
Newsletter | September 2022.
myBrain Technologies is committed to provide the most accurate offer possible to support its customers in the development of their products. With the
Newsletter | Summer 2022.
Statistics are here! Discover now our new statistic tools in Analytics to easily interpret your protocol results. Easily navigate, clearly see and qu
Newsletter | June 2022.
As a company that has developed a solution based on Artificial Intelligence (AI) and neuroscience ans as manufacturer of Medical Devices (MD), myBrain
![[DOWNLOAD] Artificial Intelligence Act: What future for AI in Europe?](https://emmanuel-guerin.fr/dev-mybraintech/wp-content/uploads/2022/06/white-paper-artificial-intellifence-act.png)
[DOWNLOAD] Artificial Intelligence Act: What future for AI in Europe?
With the increasing evolution of computing, robotics, and new technologies, AI is now a major part of our daily life. On April 21, 2021, the European
myBrain Technologies’s eye on Medical Device Regulation.
In order to improve health safety and harmonize rules within the EU, the Medical Device Regulation has been profoundly revised, resulting in new regul
Newsletter | May 2022.
Our brain still holds many secrets, both in its functionning and in its normal development. Thanks to the latest neurosciences techniques and tools, i
NeuroAeronautics: brain wave monitoring in the ‘Cockpit of the Future’.
A cockpit is a highly sensitive area, where attention and mental workload have to be optimized. Latest neurotechnologies, including EEG, can track bra
Newsletter | April 2022.
This month, the spotlight is on user experience that our Product Team keep on improving. We aim to focus on our customer's feedback to optimize our so
NeuroDesign: to perfect the symbiosis between a product and the user experience.
One of the key aspects of product strategy is to generate, identify and leverage insights that will provide the foundation to reach business objective
Newsletter | March 2022.
Hi there! The cosmetic industry has been interested for a while in exploring the links between the brain and the nervous system. The recent advances i
NeuroCosmetics in skincare.
Cutting edge “neuro-IA” technologies can detect the physiological impact of a cosmetic product using real-time consumers’ emotional data collect
Newsletter | February 2022.
First of all, we're deeply happy to have seen so many of you reading us last month and we thank you very much! Today, we are proud to announce that o
Neuroergonomics: towards a new paradigm of product design.
Neuroergonomics provides a multidisciplinary approach that merges elements of neuroscience, human factors, and ergonomics to study brain response to s
Newsletter | January 2022.
2021 has been full of exciting happenings. Since the very beginning of our adventure, we are dedicated to improve the life of others with neuroscienc
Press Release: Decoding the brain to understand human cognition and emotions.
myBrain Tech has developed its Neuromarkers platform to record, analyze and interpret the brain's electrical signals in real time. With this solution,
[SAVE THE DATE] – AI, conquering emotions in Health!
On Tuesday, November 16, 2021, at 11am, come and listen to Giuseppe Spinelli at the microphone of Pascal Becache on the occasion of the 4th Webinar #P
Computational Psychiatry: how neurotechnology is changing the world of mental health ?
Neuroscience and artificial intelligence are about to revolutionize medicine, especially psychiatry. Neurotechnologies offer a range of new tools base
The path to ISO 13485.
Implementing a quality approach within a start-up poses particular difficulties linked to the context of innovation, agility and rapid growth. However
Get in touch
We are glad you are interested in reaching out to us. Whether you have a question about our products or want to give us feedback, we are here to help.
Laisser un commentaire